Astro Malaysia Holdings Berhad Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag

Astro Malaysia Holdings Berhad (KLSE:ASTRO) Full Year 2025 Results

Key Financial Results

• Revenue: RM3.08b (down 8.0% from FY 2024).
• Net income: RM129.1m (up 205% from FY 2024).
• Profit margin: 4.2% (up from 1.3% in FY 2024). The increase in margin was driven by lower expenses.
• EPS: RM0.025 (up from RM0.008 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Astro Malaysia Holdings Berhad EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) exceeded analyst estimates by 49%.

The primary driver behind last 12 months revenue was the Television segment contributing a total revenue of RM2.91b (95% of total revenue). Notably, cost of sales worth RM2.25b amounted to 73% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to RM294.6m (42% of total expenses). Explore how ASTRO's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Media industry in Malaysia.

Performance of the Malaysian Media industry.

The company's shares are up 14% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for Astro Malaysia Holdings Berhad (2 make us uncomfortable!) that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.